CRONOS-MS · COMB157GES01
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice: the CRONOS-MS Study.
Sponsor: NOVARTIS
Phase: IV
Area: Neuroimmunology